CoQ10

DRUG14 trials

Sponsors

Mitsui Jun, University of Rochester, Lahey Clinic, Johns Hopkins University, Columbia University

Conditions

AneuploidyAtaxia-oculomotor Apraxia 1Breast CancerChronic Kidney DiseaseCoenzyme Q10 PharmacokineticsCoenzyme Q10 on Athero-thrombosis in APS PatientsCrohn DiseaseEnd Stage Renal Disease

Early Phase 1

Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study

Active, not recruitingNCT06419335

University of PennsylvaniaCrohn Disease, Healthy

Start: 2024-07-20End: 2026-09-01Target: 60Updated: 2026-06-04

Phase 1

Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer

CompletedNCT00976131

Columbia UniversityBreast Cancer

Start: 2009-09-30End: 2021-01-20Updated: 2022-10-17

Phase 2

NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485

CompletedNCT00076492

University of RochesterParkinson Disease

Start: 2004-01-31End: 2005-09-30Target: 195Updated: 2012-11-02

Effects of Coenzyme Q10 in PSP and CBD

CompletedNCT00532571

Lahey ClinicNeurological Disorders, Progressive Supranuclear Palsy

Start: 2004-01-31End: 2005-09-30Updated: 2018-06-15

Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)

CompletedNCT00920699

Johns Hopkins UniversityHuntington's Disease

Start: 2010-02-28End: 2012-03-31Updated: 2017-09-25

CoQ10 and D-ribose in Patients With Diastolic Heart Failure

CompletedNCT03133793

University of Kansas Medical CenterHeart Failure, Diastolic

Start: 2018-02-05End: 2021-03-12Updated: 2022-03-18

Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease

CompletedNCT03579693

University of WashingtonChronic Kidney Disease, Frailty, Sarcopenia

Start: 2018-11-14End: 2021-04-26Updated: 2023-01-10

Phase 3

Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10

CompletedNCT02333305

Assistance Publique - Hôpitaux de ParisAtaxia-oculomotor Apraxia 1

Start: 2013-06-30End: 2017-09-30Updated: 2017-11-06

Efficacy of Coenzyme Q10 Supplementation on Multi-Organ Dysfunction in Severely Burned Patients

WithdrawnNCT03968640

American Burn AssociationMultiple Organ Failure

Start: 2018-07-01End: 2020-07-17Updated: 2023-07-20

CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

RecruitingNCT05422534

Vanderbilt University Medical CenterEnd Stage Renal Disease

Start: 2023-06-01End: 2027-10-01Target: 156Updated: 2026-01-02

RecruitingJPRN-jRCT2031250696

Mitsui JunMultiple System Atrophy (MSA) Multiple System Atrophy

Start: 2026-02-09Target: 140Updated: 2026-06-29

Unknown Phase

Aneuploidy Rates in Advanced Maternal Age Patients Supplemented With Coenzyme Q10 (CoQ10) Versus Those That Are Not: a Pilot Study

CompletedNCT02119117

Reproductive Endocrinology Associates of CharlotteAneuploidy, Mitochondrial DNA

Start: 2014-04-30End: 2018-05-31Updated: 2018-05-04

Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome Patients

Maimónides Biomedical Research Institute of CórdobaCoenzyme Q10 on Athero-thrombosis in APS Patients

Start: 2013-09-30Target: 50Updated: 2014-08-18

Pharmacokinetics of Different CoQ10 Formulations

CompletedNCT06151171

Factors Group of Nutritional Companies Inc.Coenzyme Q10 Pharmacokinetics

Start: 2022-03-01End: 2022-10-31Updated: 2023-12-05

Related Papers

A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD

Clinical Journal of the American Society of Nephrology2025-01-233 citations

Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment

Integrative Cancer Therapies2025-01-011 citations

Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease

JCI Insight2023-05-0933 citations

Abstract 10196: Reducing Symptom Burden Using Ubiquinol And/Or D-Ribose in Patients With Heart Failure With Preserved Ejection Fraction

Circulation2022-11-08

Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose

BMC Cardiovascular Disorders2018-04-0230 citations

Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile

Arteriosclerosis Thrombosis and Vascular Biology2017-07-0678 citations

Measuring Disease Progression in Early Parkinson Disease

JAMA Neurology2014-04-0785 citations